back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-09 12:04 Tx date 2024-01-05 |
$ONC
Oncolytics Biotech Inc. |
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,200
+45,000 vol $1.76 each |
45,000 | |
| Filed 2024-01-09 11:46 Tx date 2024-01-05 |
$ONC
Oncolytics Biotech Inc. |
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,200
+45,000 vol $1.76 each |
||
| Filed 2024-01-09 11:46 Tx date 2024-01-05 |
$ONC
Oncolytics Biotech Inc. |
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,200
+45,000 vol $1.76 each |
45,000 | |
| Filed 2024-01-09 11:42 Tx date 2024-01-05 |
$ONC
Oncolytics Biotech Inc. |
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-13 15:19 Tx date 2023-12-11 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,105 vol |
||
| Filed 2023-12-13 15:05 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+15,200 vol |
21,100 | |
| Filed 2023-12-13 15:05 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$108,297
+56,700 vol $1.91 each |
208,400 | |
| Filed 2023-12-13 15:03 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+62,100 vol |
86,000 | |
| Filed 2023-12-13 15:02 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$442,547
+231,700 vol $1.91 each |
745,600 | |
| Filed 2023-12-13 15:00 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+19,500 vol |
25,400 | |
| Filed 2023-12-13 14:59 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$139,048
+72,800 vol $1.91 each |
602,183 | |
| Filed 2023-12-13 14:57 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+62,100 vol |
90,300 | |
| Filed 2023-12-13 14:57 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$442,547
+231,700 vol $1.91 each |
1,098,962 | |
| Filed 2023-12-13 14:54 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+93,800 vol |
174,500 | |
| Filed 2023-12-13 14:52 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$668,500
+350,000 vol $1.91 each |
1,855,631 | |
| Filed 2023-12-12 09:57 Tx date 2023-12-11 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,105 vol |
||
| Filed 2023-12-12 09:54 Tx date 2023-12-11 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,157 vol |
112,500 | |
| Filed 2023-11-20 10:22 Tx date 2023-11-19 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,000 vol |
867,262 | |
| Filed 2023-11-20 09:36 Tx date 2023-11-19 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-150,000 vol |
1,505,631 | |
| Filed 2023-11-17 09:37 Tx date 2023-11-15 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-145,000
-100,000 vol $1.45 each |
484,857 | |
| Filed 2023-08-18 11:57 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+80,700 vol |
80,700 | |
| Filed 2023-08-18 11:56 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,900 vol |
5,900 | |
| Filed 2023-08-18 11:55 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,891
+21,700 vol $2.76 each |
584,857 | |
| Filed 2023-08-18 11:54 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,900 vol |
5,900 | |
| Filed 2023-08-18 11:53 Tx date 2023-02-24 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-18 11:53 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,891
+21,700 vol $2.76 each |
151,700 | |
| Filed 2023-08-18 11:51 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+23,900 vol |
23,900 | |
| Filed 2023-08-18 11:50 Tx date 2020-08-01 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-18 11:49 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$245,363
+88,900 vol $2.76 each |
513,900 | |
| Filed 2023-08-18 11:47 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,900 vol |
5,900 | |
| Filed 2023-08-18 11:46 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-18 11:45 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,891
+21,700 vol $2.76 each |
529,383 | |
| Filed 2023-08-18 11:43 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+28,200 vol |
28,200 | |
| Filed 2023-08-18 11:41 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$289,800
+105,000 vol $2.76 each |
920,262 | |
| Filed 2023-08-18 11:38 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$830,759
+301,000 vol $2.76 each |
1,655,631 | |
| Filed 2023-08-18 11:36 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+30,000 vol $2.76 each |
95,263 | |
| Filed 2023-08-18 11:34 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Rigby, Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+30,000 vol $2.76 each |
75,000 | |
| Filed 2023-08-18 11:32 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$103,499
+37,500 vol $2.76 each |
115,657 | |
| Filed 2023-08-18 11:28 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+30,000 vol $2.76 each |
75,000 | |
| Filed 2023-08-18 11:26 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+30,000 vol $2.76 each |
95,263 | |
| Filed 2023-08-18 11:24 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+30,000 vol $2.76 each |
95,263 | |
| Filed 2023-05-10 11:09 Tx date 2023-05-09 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-5,263 vol |
78,157 | |
| Filed 2023-02-24 12:45 Tx date 2023-02-24 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
130,000 | ||
| Filed 2022-12-19 10:44 Tx date 2022-12-17 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-13,157 vol |
1,354,631 | |
| Filed 2022-12-19 10:40 Tx date 2022-12-17 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,210 vol |
815,262 | |
| Filed 2022-12-13 12:49 Tx date 2022-12-09 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$231,000
+100,000 vol $2.31 each |
1,367,788 | |
| Filed 2022-12-13 12:42 Tx date 2022-12-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$184,800
+80,000 vol $2.31 each |
819,472 | |
| Filed 2022-12-13 12:32 Tx date 2022-12-09 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$184,800
+80,000 vol $2.31 each |
563,157 | |
| Filed 2022-12-13 12:26 Tx date 2022-12-09 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$184,800
+80,000 vol $2.31 each |
425,000 | |
| Filed 2022-12-13 12:20 Tx date 2022-12-12 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-526 vol |
507,683 | |
| Filed 2022-12-13 12:16 Tx date 2022-12-09 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$184,800
+80,000 vol $2.31 each |
508,209 | |
| Filed 2022-11-14 15:29 Tx date 2022-11-13 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-21,052 vol |
739,472 | |
| Filed 2022-09-08 15:50 Tx date 2022-08-30 |
$ONC
Oncolytics Biotech Inc. |
Rigby, Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,800
+45,000 vol $1.84 each |
45,000 | |
| Filed 2022-09-08 15:46 Tx date 2022-08-30 |
$ONC
Oncolytics Biotech Inc. |
Rigby, Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-23 10:00 Tx date 2022-06-20 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,299
+45,000 vol $1.14 each |
45,000 | |
| Filed 2022-06-23 09:57 Tx date 2022-06-16 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-21 15:44 Tx date 2022-06-20 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,200
+30,000 vol $1.14 each |
65,263 | |
| Filed 2022-06-21 15:42 Tx date 2022-06-20 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,200
+30,000 vol $1.14 each |
65,263 | |
| Filed 2022-06-21 15:40 Tx date 2022-06-20 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,200
+30,000 vol $1.14 each |
65,263 | |
| Filed 2022-06-21 15:37 Tx date 2022-06-20 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,749
+37,500 vol $1.14 each |
83,420 | |
| Filed 2022-06-17 11:22 Tx date 2022-06-16 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,851
+4,200 vol $1.16 each |
4,200 | |
| Filed 2022-06-17 11:21 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-16 09:40 Tx date 2022-06-15 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,340
+6,000 vol $0.89 each |
45,028 | |
| Filed 2022-06-15 14:59 Tx date 2022-06-15 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,669
+7,900 vol $0.84 each |
96,333 | |
| Filed 2022-06-14 17:00 Tx date 2022-06-14 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,429
+11,000 vol $0.86 each |
11,000 | |
| Filed 2022-06-14 16:59 Tx date 2020-08-01 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-14 16:00 Tx date 2022-06-14 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,160
+6,000 vol $0.86 each |
39,028 | |
| Filed 2022-06-14 15:17 Tx date 2022-06-14 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,065
+50,000 vol $0.86 each |
314,863 | |
| Filed 2022-06-14 15:15 Tx date 2022-06-14 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,821
+5,774 vol $0.83 each |
88,433 | |
| Filed 2022-03-09 10:13 Tx date 2022-03-08 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-442,414.05
-59,705 vol $7.41 each |
760,524 | |
| Filed 2022-03-09 10:11 Tx date 2022-03-08 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-988,412.49
-133,389 vol $7.41 each |
1,267,788 | |
| Filed 2022-03-09 10:09 Tx date 2022-03-09 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-109,193.76
-14,736 vol $7.41 each |
483,157 | |
| Filed 2022-03-09 10:07 Tx date 2022-03-08 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-77,997.66
-10,526 vol $7.41 each |
428,209 | |
| Filed 2022-01-04 14:28 Tx date 2022-01-04 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,287 vol |
264,863 | |
| Filed 2022-01-04 14:27 Tx date 2022-01-04 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,287 vol |
0 | |
| Filed 2022-01-04 14:24 Tx date 2022-01-04 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,142 vol |
121,925 | |
| Filed 2022-01-04 14:22 Tx date 2022-01-04 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,142 vol |
0 | |
| Filed 2022-01-04 14:08 Tx date 2022-01-04 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,837 vol |
189,941 | |
| Filed 2022-01-04 14:07 Tx date 2022-01-04 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,837 vol |
0 | |
| Filed 2021-12-15 09:50 Tx date 2021-12-14 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-842 vol |
438,735 | |
| Filed 2021-12-15 09:48 Tx date 2021-12-14 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,684 vol |
820,229 | |
| Filed 2021-12-15 09:46 Tx date 2021-12-14 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-13,157 vol |
1,401,177 | |
| Filed 2021-12-13 17:42 Tx date 2021-12-10 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,400
+55,000 vol $2.08 each |
345,000 | |
| Filed 2021-12-13 17:40 Tx date 2021-12-10 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,400
+55,000 vol $2.08 each |
439,577 | |
| Filed 2021-12-13 17:35 Tx date 2021-12-10 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,400
+55,000 vol $2.08 each |
497,893 | |
| Filed 2021-12-13 17:34 Tx date 2021-12-10 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,400
+55,000 vol $2.08 each |
823,913 | |
| Filed 2021-12-13 17:32 Tx date 2021-12-10 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$135,200
+65,000 vol $2.08 each |
1,414,334 | |
| Filed 2021-10-04 18:36 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,496 vol |
48,948 | |
| Filed 2021-10-04 18:34 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
54 - Exercise of warrants
|
-8,134 vol |
0 | |
| Filed 2021-10-04 18:27 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,134 vol |
256,576 | |
| Filed 2021-10-04 18:26 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,134 vol |
8,287 | |
| Filed 2021-10-04 18:26 Tx date 2021-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,101 vol |
248,442 | |
| Filed 2021-10-04 18:24 Tx date 2021-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,101 vol |
16,421 | |
| Filed 2021-10-04 18:18 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,134 vol |
183,104 | |
| Filed 2021-10-04 18:17 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,134 vol |
6,837 | |
| Filed 2021-10-04 18:16 Tx date 2021-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,033 vol |
174,970 | |
| Filed 2021-10-04 18:15 Tx date 2021-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,033 vol |
14,971 | |
| Filed 2021-10-04 18:09 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,134 vol |
118,783 | |
| Filed 2021-10-04 18:08 Tx date 2021-10-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,134 vol |
3,142 | |
| Filed 2021-10-04 18:07 Tx date 2021-09-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,313 vol |
110,649 | |
| Filed 2021-10-04 18:04 Tx date 2021-09-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,313 vol |
11,276 | |
| Filed 2021-07-28 10:36 Tx date 2021-07-27 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-77,559.30
-1,894 vol $40.95 each |
1,349,334 | |
| Filed 2021-06-30 16:17 Tx date 2021-06-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,033 vol |
169,937 | |
| Filed 2021-06-30 16:15 Tx date 2021-06-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,033 vol |
20,004 | |
| Filed 2021-06-30 16:09 Tx date 2021-06-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,101 vol |
242,341 | |
| Filed 2021-06-30 16:06 Tx date 2021-06-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,101 vol |
22,522 | |
| Filed 2021-06-30 16:00 Tx date 2021-06-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,313 vol |
13,589 | |
| Filed 2021-06-30 11:25 Tx date 2021-06-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,933
+2,313 vol $3.43 each |
5,313 | |
| Filed 2021-06-07 12:48 Tx date 2021-06-07 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,123
+7,000 vol $3.59 each |
108,336 | |
| Filed 2021-04-01 10:31 Tx date 2021-03-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,540 vol |
164,904 | |
| Filed 2021-04-01 10:29 Tx date 2021-03-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,540 vol |
25,037 | |
| Filed 2021-04-01 10:27 Tx date 2021-03-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,079 vol |
236,240 | |
| Filed 2021-04-01 10:26 Tx date 2021-03-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,079 vol |
28,623 | |
| Filed 2021-04-01 10:24 Tx date 2021-03-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,167 vol |
101,336 | |
| Filed 2021-04-01 10:22 Tx date 2021-03-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,167 vol |
15,902 | |
| Filed 2021-03-12 19:14 Tx date 2021-03-12 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+22,105 vol |
33,028 | |
| Filed 2021-03-12 19:13 Tx date 2021-03-12 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
57 - Exercise of rights
|
-22,105 vol |
0 | |
| Filed 2021-03-12 19:12 Tx date 2021-03-12 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+34,736 vol |
82,659 | |
| Filed 2021-03-12 19:10 Tx date 2021-03-12 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
57 - Exercise of rights
|
-34,736 vol |
0 | |
| Filed 2021-03-12 18:26 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+30,000 vol $3.40 each |
35,263 | |
| Filed 2021-03-12 18:25 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+30,000 vol $3.40 each |
35,263 | |
| Filed 2021-03-12 18:23 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,500
+37,500 vol $3.40 each |
45,920 | |
| Filed 2021-03-12 18:21 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+30,000 vol $3.40 each |
80,000 | |
| Filed 2021-03-12 18:19 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+30,000 vol $3.40 each |
35,263 | |
| Filed 2021-03-12 18:17 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$102,000
+30,000 vol $3.40 each |
35,263 | |
| Filed 2021-03-12 18:15 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$527,000
+155,000 vol $3.40 each |
768,913 | |
| Filed 2021-03-12 18:13 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$408,000
+120,000 vol $3.40 each |
290,000 | |
| Filed 2021-03-12 18:11 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$153,000
+45,000 vol $3.40 each |
384,577 | |
| Filed 2021-03-12 18:09 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$289,000
+85,000 vol $3.40 each |
442,893 | |
| Filed 2021-03-12 18:06 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,428,000
+420,000 vol $3.40 each |
1,351,228 | |
| Filed 2021-02-26 15:06 Tx date 2021-02-24 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-14,500
-10,000 vol $1.45 each |
339,577 | |
| Filed 2021-02-14 16:40 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-167,963.04
-2,631 vol $63.84 each |
613,913 | |
| Filed 2021-02-14 16:34 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-772,783.20
-12,105 vol $63.84 each |
931,228 | |
| Filed 2021-02-14 16:32 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-13,406.40
-210 vol $63.84 each |
349,577 | |
| Filed 2020-12-15 10:17 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-13,406.40
-210 vol $63.84 each |
||
| Filed 2020-12-15 10:13 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-167,963.04
-2,631 vol $63.84 each |
||
| Filed 2020-12-15 10:11 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-772,783.20
-12,105 vol $63.84 each |
||
| Filed 2021-01-15 10:46 Tx date 2021-01-13 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+462 vol |
45,452 | |
| Filed 2021-01-15 10:43 Tx date 2021-01-13 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,239 vol |
8,134 | |
| Filed 2021-01-15 10:34 Tx date 2021-01-13 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,982 vol |
233,161 | |
| Filed 2021-01-15 10:32 Tx date 2021-01-13 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,982 vol |
31,702 | |
| Filed 2021-01-15 10:30 Tx date 2021-01-13 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,303 vol |
162,364 | |
| Filed 2021-01-15 10:29 Tx date 2021-01-13 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,303 vol |
27,577 | |
| Filed 2021-01-04 15:46 Tx date 2020-12-31 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,239 vol |
9,373 | |
| Filed 2021-01-04 15:43 Tx date 2020-12-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,667 vol |
231,179 | |
| Filed 2021-01-04 15:41 Tx date 2020-12-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,982 vol |
33,684 | |
| Filed 2021-01-04 15:39 Tx date 2020-12-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,667 vol |
31,702 | |
| Filed 2021-01-04 15:37 Tx date 2020-12-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,053 vol |
100,169 | |
| Filed 2021-01-04 15:36 Tx date 2020-12-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,053 vol |
17,069 | |
| Filed 2021-01-04 15:32 Tx date 2020-12-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+926 vol |
159,061 | |
| Filed 2021-01-04 15:21 Tx date 2020-12-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,303 vol |
30,880 | |
| Filed 2021-01-04 15:20 Tx date 2020-12-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-926 vol |
27,577 | |
| Filed 2020-12-16 17:04 Tx date 2020-12-11 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$317,000
+100,000 vol $3.17 each |
170,000 | |
| Filed 2020-12-16 17:01 Tx date 2020-12-11 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$634,000
+200,000 vol $3.17 each |
357,893 | |
| Filed 2020-12-16 16:59 Tx date 2020-12-11 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$634,000
+200,000 vol $3.17 each |
349,787 | |
| Filed 2020-12-16 16:57 Tx date 2020-12-11 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$792,500
+250,000 vol $3.17 each |
616,544 | |
| Filed 2020-12-16 16:55 Tx date 2020-12-11 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$951,000
+300,000 vol $3.17 each |
943,333 | |
| Filed 2020-12-15 10:17 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-13,406.40
-210 vol $63.84 each |
149,577 | |
| Filed 2020-12-15 10:13 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-167,963.04
-2,631 vol $63.84 each |
363,913 | |
| Filed 2020-12-15 10:11 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-772,783.20
-12,105 vol $63.84 each |
631,228 | |
| Filed 2020-12-02 16:08 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,713 vol |
44,990 | |
| Filed 2020-12-02 16:06 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,971 vol |
8,134 | |
| Filed 2020-12-02 16:02 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,971 vol |
229,512 | |
| Filed 2020-12-02 16:01 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,971 vol |
33,369 | |
| Filed 2020-12-02 15:59 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,971 vol |
63,761 | |
| Filed 2020-12-02 15:58 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,971 vol |
8,134 | |
| Filed 2020-12-02 15:56 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,971 vol |
158,135 | |
| Filed 2020-12-02 15:55 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,971 vol |
28,503 | |
| Filed 2020-12-02 15:52 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,971 vol |
99,116 | |
| Filed 2020-12-02 15:50 Tx date 2020-12-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,971 vol |
18,122 | |
| Filed 2020-11-10 09:55 Tx date 2020-11-09 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-9,775.50
-210 vol $46.55 each |
149,787 | |
| Filed 2020-10-06 09:45 Tx date 2020-10-01 |
$ONC
Oncolytics Biotech Inc. |
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,483 vol |
22,294 | |
| Filed 2020-10-05 19:51 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,428 vol |
43,277 | |
| Filed 2020-10-05 19:50 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-19,666 vol |
12,105 | |
| Filed 2020-10-05 19:50 Tx date 2020-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,483 vol |
31,771 | |
| Filed 2020-10-05 19:45 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+11,010 vol |
59,790 | |
| Filed 2020-10-05 19:44 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-17,483 vol |
12,105 | |
| Filed 2020-10-05 19:43 Tx date 2020-10-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,483 vol |
29,588 | |
| Filed 2020-10-05 19:30 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+23,305 vol |
154,164 | |
| Filed 2020-10-05 19:26 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-23,305 vol |
32,474 | |
| Filed 2020-10-05 19:26 Tx date 2020-10-01 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,483 vol |
55,779 | |
| Filed 2020-10-05 19:22 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+17,483 vol |
95,145 | |
| Filed 2020-10-05 19:21 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-17,483 vol |
22,093 | |
| Filed 2020-10-05 19:20 Tx date 2020-10-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,483 vol |
39,576 | |
| Filed 2020-10-05 19:16 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+20,976 vol |
225,541 | |
| Filed 2020-10-05 19:15 Tx date 2020-10-05 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-20,976 vol |
37,340 | |
| Filed 2020-10-05 19:13 Tx date 2020-10-01 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,483 vol |
58,316 | |
| Filed 2020-10-02 10:33 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,183 vol |
14,288 | |
| Filed 2020-10-02 10:29 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,811 vol |
204,565 | |
| Filed 2020-10-02 10:28 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,811 vol |
40,833 | |
| Filed 2020-10-02 10:26 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,493 vol |
42,644 | |
| Filed 2020-10-02 10:21 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,006 vol |
130,859 | |
| Filed 2020-10-02 10:18 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,006 vol |
38,296 | |
| Filed 2020-10-02 10:09 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,828 vol |
||
| Filed 2020-10-02 10:08 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+5,822 vol |
39,302 | |
| Filed 2020-10-02 10:03 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,144 vol |
77,662 | |
| Filed 2020-10-02 10:02 Tx date 2020-09-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,144 vol |
22,093 | |
| Filed 2020-08-28 10:04 Tx date 2020-08-28 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,105
+4,300 vol $2.35 each |
76,518 | |
| Filed 2020-08-05 12:12 Tx date 2020-08-01 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$198,800
+70,000 vol $2.84 each |
70,000 | |
| Filed 2020-08-05 12:08 Tx date 2020-08-01 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-07 10:46 Tx date 2020-07-06 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,896 vol |
202,754 | |
| Filed 2020-07-07 10:45 Tx date 2020-07-06 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,896 vol |
39,151 | |
| Filed 2020-07-07 10:43 Tx date 2020-07-06 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,827 vol |
129,853 | |
| Filed 2020-07-07 10:42 Tx date 2020-07-06 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-4,827 vol |
33,480 | |
| Filed 2020-07-07 10:40 Tx date 2020-07-06 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,810 vol |
34,849 | |
| Filed 2020-07-07 10:38 Tx date 2020-07-06 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,810 vol |
12,105 | |
| Filed 2020-07-07 10:35 Tx date 2020-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,210 vol |
10,315 | |
| Filed 2020-07-07 10:34 Tx date 2020-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-4,210 vol |
0 | |
| Filed 2020-07-03 10:14 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,810 vol |
4,811 | |
| Filed 2020-07-03 10:12 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,810 vol |
13,915 | |
| Filed 2020-07-03 10:08 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,368 vol |
199,858 | |
| Filed 2020-07-03 10:07 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,896 vol |
42,047 | |
| Filed 2020-07-03 10:06 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,368 vol |
39,151 | |
| Filed 2020-07-03 09:58 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,496 vol |
72,218 | |
| Filed 2020-07-03 09:56 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,496 vol |
23,237 | |
| Filed 2020-07-03 09:51 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,315 vol |
125,026 | |
| Filed 2020-07-03 09:50 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+4,827 vol |
38,307 | |
| Filed 2020-07-03 09:49 Tx date 2020-06-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,315 vol |
33,480 | |
| Filed 2020-04-06 16:46 Tx date 2020-04-06 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,383 vol |
197,490 | |
| Filed 2020-04-06 16:45 Tx date 2020-04-06 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,383 vol |
41,519 | |
| Filed 2020-04-06 16:42 Tx date 2020-04-06 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,212 vol |
33,039 | |
| Filed 2020-04-06 16:41 Tx date 2020-04-06 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,212 vol |
12,105 | |
| Filed 2020-04-06 16:39 Tx date 2020-04-06 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,165 vol |
70,722 | |
| Filed 2020-04-06 16:34 Tx date 2020-04-06 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,165 vol |
24,733 | |
| Filed 2020-04-06 16:25 Tx date 2020-04-06 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,291 vol |
123,711 | |
| Filed 2020-04-06 16:23 Tx date 2020-04-06 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-7,291 vol |
34,795 | |
| Filed 2020-04-02 10:08 Tx date 2020-03-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,539 vol |
46,902 | |
| Filed 2020-04-02 10:06 Tx date 2020-03-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+6,267 vol |
42,086 | |
| Filed 2020-04-02 10:04 Tx date 2020-03-31 |
$ONC
Oncolytics Biotech Inc. |
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,212 vol |
3,001 | |
| Filed 2020-04-02 10:02 Tx date 2020-03-31 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,212 vol |
14,317 | |
| Filed 2020-03-30 10:35 Tx date 2020-03-27 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,089
+3,000 vol $2.03 each |
3,000 | |
| Filed 2020-03-30 10:03 Tx date 2020-03-27 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+3,000 vol $2.00 each |
||
| Filed 2020-03-30 10:02 Tx date 2014-06-18 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-30 09:48 Tx date 2020-03-27 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+3,000 vol $2.00 each |
69,557 | |
| Filed 2020-03-09 10:21 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
157,893 | |
| Filed 2020-03-09 10:20 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$253,750
+175,000 vol $1.45 each |
643,333 | |
| Filed 2020-03-09 10:19 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,250
+125,000 vol $1.45 each |
366,544 | |
| Filed 2020-03-09 10:17 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,750
+35,000 vol $1.45 each |
87,893 | |
| Filed 2020-03-09 10:15 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,250
+125,000 vol $1.45 each |
175,000 | |
| Filed 2020-03-09 10:13 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
159,997 | |
| Filed 2019-12-18 15:52 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,750
+35,000 vol $1.45 each |
||
| Filed 2019-12-18 15:49 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
||
| Filed 2019-12-18 15:43 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,250
+125,000 vol $1.45 each |
||
| Filed 2019-12-18 15:39 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
||
| Filed 2019-12-18 15:35 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,250
+125,000 vol $1.45 each |
||
| Filed 2019-12-18 15:32 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$253,750
+175,000 vol $1.45 each |
||
| Filed 2020-02-21 15:57 Tx date 2020-02-20 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,210 vol |
9,315 | |
| Filed 2020-02-21 15:56 Tx date 2020-02-20 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
57 - Exercise of rights
|
-4,210 vol |
0 | |
| Filed 2020-01-17 10:59 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,968 vol |
66,557 | |
| Filed 2020-01-17 10:54 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,526 vol |
192,107 | |
| Filed 2020-01-17 10:52 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-10,526 vol |
43,363 | |
| Filed 2020-01-17 10:50 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,526 vol |
48,780 | |
| Filed 2020-01-17 10:47 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-10,526 vol |
12,105 | |
| Filed 2020-01-17 10:43 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,526 vol |
||
| Filed 2020-01-17 10:38 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-10,526 vol |
25,898 | |
| Filed 2020-01-17 10:35 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+15,789 vol |
116,420 | |
| Filed 2020-01-17 10:33 Tx date 2020-01-16 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-15,789 vol |
35,819 | |
| Filed 2020-01-10 18:18 Tx date 2020-01-06 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-66,995.60
-14,000 vol $4.79 each |
30,827 | |
| Filed 2020-01-10 15:29 Tx date 2020-01-06 |
$ONC
Oncolytics Biotech Inc. |
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+789 vol |
789 | |
| Filed 2020-01-10 15:28 Tx date 2019-10-02 |
$ONC
Oncolytics Biotech Inc. |
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-08 16:00 Tx date 2020-01-06 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,413 vol |
181,581 | |
| Filed 2020-01-08 15:54 Tx date 2020-01-06 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,282 vol |
51,608 | |
| Filed 2020-01-08 15:53 Tx date 2020-01-06 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,748 vol |
57,890 | |
| Filed 2020-01-08 14:35 Tx date 2020-01-06 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-14,500
-10,000 vol $1.45 each |
149,997 | |
| Filed 2019-12-18 15:52 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,750
+35,000 vol $1.45 each |
87,893 | |
| Filed 2019-12-18 15:49 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
159,997 | |
| Filed 2019-12-18 15:43 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,250
+125,000 vol $1.45 each |
175,000 | |
| Filed 2019-12-18 15:39 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$145,000
+100,000 vol $1.45 each |
157,893 | |
| Filed 2019-12-18 15:35 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,250
+125,000 vol $1.45 each |
366,544 | |
| Filed 2019-12-18 15:32 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$253,750
+175,000 vol $1.45 each |
643,333 | |
| Filed 2019-12-09 10:21 Tx date 2019-12-08 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-91,773.99
-3,157 vol $29.07 each |
468,333 | |
| Filed 2019-12-09 10:17 Tx date 2019-12-08 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-30,581.64
-1,052 vol $29.07 each |
241,544 | |
| Filed 2019-10-21 17:25 Tx date 2019-10-02 |
$ONC
Oncolytics Biotech Inc. |
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+50,000 vol $0.54 each |
50,000 | |
| Filed 2019-10-21 17:21 Tx date 2019-10-02 |
$ONC
Oncolytics Biotech Inc. |
Kruimer, Leonard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-08 09:49 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,377 vol |
22,631 | |
| Filed 2019-10-08 09:45 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,182 vol |
38,254 | |
| Filed 2019-10-08 09:44 Tx date 2019-10-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,377 vol |
||
| Filed 2019-10-04 11:32 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,377 vol |
178,168 | |
| Filed 2019-10-04 11:31 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+44,827 vol |
93,791 | |
| Filed 2019-10-04 11:31 Tx date 2019-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+10,136 vol |
48,964 | |
| Filed 2019-10-04 11:23 Tx date 2019-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-10,136 vol |
63,786 | |
| Filed 2019-10-04 11:17 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,377 vol |
55,409 | |
| Filed 2019-10-04 11:13 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-44,827 vol |
63,786 | |
| Filed 2019-10-04 11:10 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+44,827 vol |
108,613 | |
| Filed 2019-10-04 11:10 Tx date 2019-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-10,139 vol |
||
| Filed 2019-10-04 11:09 Tx date 2019-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,963 vol |
73,922 | |
| Filed 2019-10-04 11:03 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,377 vol |
94,349 | |
| Filed 2019-10-04 11:02 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+44,827 vol |
85,972 | |
| Filed 2019-10-04 11:01 Tx date 2019-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+19,695 vol |
41,145 | |
| Filed 2019-10-04 11:00 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,377 vol |
54,142 | |
| Filed 2019-10-04 10:59 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-44,827 vol |
62,519 | |
| Filed 2019-10-04 10:58 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+44,827 vol |
107,346 | |
| Filed 2019-10-04 10:56 Tx date 2019-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-19,695 vol |
62,519 | |
| Filed 2019-10-04 10:55 Tx date 2019-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,739 vol |
82,214 | |
| Filed 2019-10-04 10:43 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+27,809 vol |
33,072 | |
| Filed 2019-10-04 10:39 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-44,827 vol |
31,008 | |
| Filed 2019-10-04 10:38 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+44,827 vol |
75,835 | |
| Filed 2019-10-04 10:35 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,377 vol |
62,589 | |
| Filed 2019-10-04 10:34 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+44,827 vol |
54,212 | |
| Filed 2019-10-04 10:32 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,377 vol |
36,424 | |
| Filed 2019-10-04 10:31 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-44,827 vol |
44,801 | |
| Filed 2019-10-04 10:30 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+44,827 vol |
89,628 | |
| Filed 2019-10-04 10:24 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+44,827 vol |
44,827 | |
| Filed 2019-10-04 10:23 Tx date 2017-11-02 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-04 10:22 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-44,827 vol |
12,105 | |
| Filed 2019-10-04 10:21 Tx date 2019-10-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+44,827 vol |
56,932 | |
| Filed 2019-10-03 15:51 Tx date 2019-10-03 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,230
+38,000 vol $0.58 each |
114,828 | |
| Filed 2019-10-02 15:54 Tx date 2019-10-02 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,040
+38,000 vol $0.58 each |
76,828 | |
| Filed 2019-10-02 15:08 Tx date 2019-10-02 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,270
+10,000 vol $0.427 each |
47,923 | |
| Filed 2019-08-16 10:55 Tx date 2019-08-16 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,125
+25,000 vol $0.60 each |
38,828 | |
| Filed 2019-07-03 13:53 Tx date 2019-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,105 vol |
6,105 | |
| Filed 2019-07-03 13:51 Tx date 2019-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,105 vol |
4,210 | |
| Filed 2019-07-02 13:11 Tx date 2019-06-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,217 vol |
13,828 | |
| Filed 2019-07-02 13:10 Tx date 2019-06-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-4,217 vol |
64,959 | |
| Filed 2019-07-02 13:08 Tx date 2019-06-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,406 vol |
69,176 | |
| Filed 2019-07-02 13:04 Tx date 2019-06-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,094 vol |
21,450 | |
| Filed 2019-07-02 13:03 Tx date 2019-06-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,094 vol |
64,475 | |
| Filed 2019-07-02 13:02 Tx date 2019-06-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+6,742 vol |
72,569 | |
| Filed 2019-06-18 16:36 Tx date 2019-06-18 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,951
+1,300 vol $2.27 each |
37,923 | |
| Filed 2019-06-18 15:35 Tx date 2019-06-18 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,370
+1,500 vol $2.25 each |
10,923 | |
| Filed 2019-04-02 14:31 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+965 vol |
9,385 | |
| Filed 2019-04-02 10:51 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,575 vol |
||
| Filed 2019-04-02 10:51 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,575 vol |
10,995 | |
| Filed 2019-04-02 10:50 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-2,575 vol |
44,801 | |
| Filed 2019-04-02 10:49 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,575 vol |
47,376 | |
| Filed 2019-04-02 10:47 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,733 vol |
9,611 | |
| Filed 2019-04-02 10:45 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-3,733 vol |
65,770 | |
| Filed 2019-04-02 10:45 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,170 vol |
69,503 | |
| Filed 2019-04-02 10:39 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,621 vol |
13,356 | |
| Filed 2019-04-02 10:37 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-4,621 vol |
65,827 | |
| Filed 2019-04-02 10:36 Tx date 2019-03-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,368 vol |
70,448 | |
| Filed 2019-02-28 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,263 vol |
||
| Filed 2019-02-28 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,263 vol |
31,008 | |
| Filed 2019-02-25 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
59,997 | ||
| Filed 2019-02-25 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
4,210 | ||
| Filed 2019-02-25 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,105 | ||
| Filed 2019-02-25 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-02-25 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
52,893 | ||
| Filed 2019-01-28 Tx date 2018-12-21 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,775
+12,500 vol $1.74 each |
||
| Filed 2019-01-28 Tx date 2018-12-21 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$2,158
+1,250 vol $1.73 each |
36,623 | |
| Filed 2019-01-02 Tx date 2018-12-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,287 vol |
66,333 | |
| Filed 2019-01-02 Tx date 2018-12-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+6,837 vol |
67,080 | |
| Filed 2019-01-02 Tx date 2018-12-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,367 vol |
8,735 | |
| Filed 2019-01-02 Tx date 2018-12-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,367 vol |
60,243 | |
| Filed 2019-01-02 Tx date 2018-12-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,142 vol |
44,801 | |
| Filed 2019-01-02 Tx date 2018-12-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-615 vol |
58,046 | |
| Filed 2019-01-02 Tx date 2018-12-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+615 vol |
5,878 | |
| Filed 2018-12-22 Tx date 2018-12-21 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,007
+1,250 vol $2.41 each |
9,423 | |
| Filed 2018-12-22 Tx date 2018-12-21 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,775
+12,500 vol $1.74 each |
47,873 | |
| Filed 2018-12-18 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
37 - Stock split or consolidation
|
-53,685 vol |
6,315 | |
| Filed 2018-12-18 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-237,107 vol |
27,893 | |
| Filed 2018-12-18 Tx date 2018-12-14 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$81,900
+30,000 vol $2.73 each |
57,893 | |
| Filed 2018-12-18 Tx date 2018-12-14 |
$ONC
Oncolytics Biotech Inc. |
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,950
+15,000 vol $2.73 each |
50,000 | |
| Filed 2018-12-12 Tx date 2018-12-11 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,389
+4,000 vol $2.10 each |
4,000 | |
| Filed 2018-12-12 Tx date 2018-12-11 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,145
+5,000 vol $2.03 each |
35,373 | |
| Filed 2018-12-12 Tx date 2018-12-11 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,275
+4,100 vol $2.75 each |
8,173 | |
| Filed 2018-12-12 Tx date 2017-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,263 vol |
58,661 | |
| Filed 2018-11-30 Tx date 2018-11-27 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+20,336 vol |
63,924 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
37 - Stock split or consolidation
|
-370,562 vol |
43,588 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
37 - Stock split or consolidation
|
-239,178 vol |
28,137 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-44,737 vol |
5,263 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
37 - Stock split or consolidation
|
-413,770 vol |
48,673 | |
| Filed 2018-11-30 Tx date 2018-11-27 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,134 vol |
36,271 | |
| Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,263 vol |
7,368 | |
| Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,263 vol |
5,263 | |
| Filed 2018-11-30 Tx date 2018-11-27 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+18,200 vol |
66,873 | |
| Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,263 vol |
31,008 | |
| Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,263 vol |
5,263 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-136,449 vol |
16,051 | |
| Filed 2018-11-30 Tx date 2018-11-27 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,134 vol |
12,105 | |
| Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,263 vol |
31,008 | |
| Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,263 vol |
61,610 | |
| Filed 2018-11-30 Tx date 2018-11-27 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,134 vol |
36,271 | |
| Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,263 vol |
8,420 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-44,737 vol |
5,263 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-20,579 vol |
2,421 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
37 - Stock split or consolidation
|
-33,758 vol |
3,971 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
37 - Stock split or consolidation
|
-239,178 vol |
28,137 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
37 - Stock split or consolidation
|
-290,427 vol |
34,162 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-71,580 vol |
8,420 | |
| Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,267 vol |
4,688 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-26,843 vol |
3,157 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-17,895 vol |
2,105 | |
| Filed 2018-11-30 Tx date 2018-11-27 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,760 vol |
46,922 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-44,737 vol |
5,263 | |
| Filed 2018-11-30 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-44,737 vol |
5,263 | |
| Filed 2018-11-30 Tx date 2018-11-29 |
$ONC
Oncolytics Biotech Inc. |
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
35,000 | |
| Filed 2018-11-30 Tx date 2018-11-28 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-5,263 vol |
41,659 | |
| Filed 2018-11-30 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-30 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-30 Tx date 2018-11-29 |
$ONC
Oncolytics Biotech Inc. |
Laeufle, Rita
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
| Filed 2018-11-23 Tx date 2018-11-19 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$182,320
+53,000 vol $3.44 each |
242,596 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
37 - Stock split or consolidation
|
-295,264 vol |
34,736 | |
| Filed 2018-11-23 Tx date 2018-11-19 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$516,000
+150,000 vol $3.44 each |
471,490 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-34,627 vol |
4,073 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
37 - Stock split or consolidation
|
-187,895 vol |
22,105 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-258,177 vol |
30,373 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,732,710 vol |
321,490 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,611,604 vol |
189,596 | |
| Filed 2018-04-04 Tx date 2018-03-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+29,251 vol |
414,150 | |
| Filed 2018-04-04 Tx date 2018-03-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+24,132 vol |
462,443 | |
| Filed 2018-04-04 Tx date 2018-03-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+11,091 vol |
324,589 | |
| Filed 2018-03-16 Tx date 2018-03-15 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$442,416
+567,200 vol $0.78 each |
1,801,200 | |
| Filed 2018-03-16 Tx date 2018-03-15 |
$ONC
Oncolytics Biotech Inc. |
Gutierrez-Lopez, Andres Alfonso
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$234,000
+300,000 vol $0.78 each |
450,000 | |
| Filed 2018-03-16 Tx date 2018-03-15 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$109,200
+140,000 vol $0.78 each |
265,000 | |
| Filed 2018-03-16 Tx date 2018-03-15 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$988,416
+1,267,200 vol $0.78 each |
3,054,200 | |
| Filed 2018-01-02 Tx date 2017-12-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+15,842 vol |
384,899 | |
| Filed 2018-01-02 Tx date 2017-12-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,801 vol |
438,311 | |
| Filed 2018-01-02 Tx date 2017-12-31 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+10,011 vol |
313,498 | |
| Filed 2017-12-13 Tx date 2017-12-12 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-19,980
-9,000 vol $2.22 each |
1,234,000 | |
| Filed 2017-12-13 Tx date 2017-12-12 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-38,850
-17,500 vol $2.22 each |
152,500 | |
| Filed 2017-12-13 Tx date 2017-12-12 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-73,999.26
-33,333 vol $2.22 each |
1,787,000 | |
| Filed 2017-12-04 Tx date 2017-12-01 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+37,729 vol |
369,057 | |
| Filed 2017-12-04 Tx date 2017-12-01 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+37,729 vol |
267,315 | |
| Filed 2017-12-04 Tx date 2017-12-01 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+37,729 vol |
429,510 | |
| Filed 2017-12-04 Tx date 2017-12-01 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+37,729 vol |
267,315 | |
| Filed 2017-12-04 Tx date 2017-12-01 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+37,729 vol |
303,487 | |
| Filed 2017-12-04 Tx date 2017-12-01 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+37,729 vol |
37,729 | |
| Filed 2017-12-04 Tx date 2017-11-02 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-11-09 Tx date 2017-11-07 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$28,499
+50,000 vol $0.57 each |
50,000 | |
| Filed 2017-11-09 Tx date 2017-11-02 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-04 Tx date 2017-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,212 vol |
331,328 | |
| Filed 2017-10-04 Tx date 2017-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+9,562 vol |
391,781 | |
| Filed 2017-10-04 Tx date 2017-09-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+10,877 vol |
265,758 | |
| Filed 2017-07-05 Tx date 2017-06-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+22,500 vol |
314,116 | |
| Filed 2017-07-05 Tx date 2017-06-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,500 vol |
382,219 | |
| Filed 2017-07-05 Tx date 2017-06-30 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+14,219 vol |
254,881 | |
| Filed 2017-07-05 Tx date 2017-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+60,000 vol |
60,000 | |
| Filed 2017-07-05 Tx date 2017-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-05 Tx date 2017-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$65,000
+125,000 vol $0.52 each |
125,000 | |
| Filed 2017-07-05 Tx date 2017-07-03 |
$ONC
Oncolytics Biotech Inc. |
de Guttadauro, Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-11 Tx date 2017-04-06 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+17,527 vol |
291,616 | |
| Filed 2017-04-11 Tx date 2017-04-06 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+9,737 vol |
369,719 | |
| Filed 2017-04-11 Tx date 2017-04-06 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+11,076 vol |
240,662 | |
| Filed 2017-01-19 Tx date 2017-01-16 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
274,089 | |
| Filed 2017-01-19 Tx date 2017-01-16 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
229,586 | |
| Filed 2017-01-19 Tx date 2017-01-16 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
359,982 | |
| Filed 2017-01-19 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+210,000 vol |
||
| Filed 2017-01-19 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+210,000 vol |
210,000 | |
| Filed 2017-01-19 Tx date 2012-11-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-01-19 Tx date 2017-01-18 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-10,575
-4,700 vol $2.25 each |
1,243,000 | |
| Filed 2017-01-19 Tx date 2017-01-16 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,000
+300,000 vol $0.28 each |
1,247,700 | |
| Filed 2017-01-19 Tx date 2017-01-16 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
229,586 | |
| Filed 2017-01-19 Tx date 2017-01-18 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-22,500
-10,000 vol $2.25 each |
170,000 | |
| Filed 2017-01-19 Tx date 2017-01-16 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+100,000 vol |
229,586 | |
| Filed 2017-01-19 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+330,000 vol |
||
| Filed 2017-01-19 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+330,000 vol |
330,000 | |
| Filed 2017-01-19 Tx date 2003-04-17 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-01-19 Tx date 2017-01-16 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,000
+400,000 vol $0.28 each |
1,820,333 | |
| Filed 2017-01-04 Tx date 2016-12-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+14,444 vol |
174,089 | |
| Filed 2017-01-04 Tx date 2016-12-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+24,073 vol |
209,982 | |
| Filed 2016-11-23 Tx date 2016-11-10 |
$ONC
Oncolytics Biotech Inc. |
Gutierrez-Lopez, Andres Alfonso
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+300,000 vol |
300,000 | |
| Filed 2016-11-23 Tx date 2016-10-31 |
$ONC
Oncolytics Biotech Inc. |
Gutierrez-Lopez, Andres Alfonso
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-23 Tx date 2016-11-10 |
$ONC
Oncolytics Biotech Inc. |
Gutierrez-Lopez, Andres Alfonso
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,000
+150,000 vol $0.26 each |
150,000 | |
| Filed 2016-11-23 Tx date 2016-10-31 |
$ONC
Oncolytics Biotech Inc. |
Gutierrez-Lopez, Andres Alfonso
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-10-06 Tx date 2016-10-03 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+79,586 vol |
159,645 | |
| Filed 2016-10-06 Tx date 2016-10-03 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+79,586 vol |
129,586 | |
| Filed 2016-10-06 Tx date 2016-10-03 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+79,586 vol |
185,909 | |
| Filed 2016-10-06 Tx date 2016-10-03 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+79,586 vol |
129,586 | |
| Filed 2016-10-06 Tx date 2016-10-03 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+79,586 vol |
129,586 | |
| Filed 2016-10-05 Tx date 2016-09-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+11,152 vol |
80,059 | |
| Filed 2016-10-05 Tx date 2016-09-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+18,587 vol |
106,323 | |
| Filed 2016-09-13 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Thompson, Bradley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+660,000 vol |
660,000 | |
| Filed 2016-09-13 Tx date 2003-04-04 |
$ONC
Oncolytics Biotech Inc. |
Thompson, Bradley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-13 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+210,000 vol |
210,000 | |
| Filed 2016-09-13 Tx date 2012-11-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-13 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+330,000 vol |
330,000 | |
| Filed 2016-09-13 Tx date 2003-04-17 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-05 Tx date 2016-06-30 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+7,706 vol |
68,907 | |
| Filed 2016-07-05 Tx date 2016-06-30 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,844 vol |
87,736 | |
| Filed 2016-04-05 Tx date 2016-03-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$2,249
+5,357 vol $0.42 each |
61,201 | |
| Filed 2016-04-05 Tx date 2016-03-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$5,000
+11,905 vol $0.42 each |
74,892 | |
| Filed 2016-01-04 Tx date 2015-12-31 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$2,249
+5,844 vol $0.385 each |
55,844 | |
| Filed 2016-01-04 Tx date 2015-12-31 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$4,999
+12,987 vol $0.385 each |
62,987 | |
| Filed 2015-12-14 Tx date 2015-12-09 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$20,000
+50,000 vol $0.40 each |
50,000 | |
| Filed 2015-12-14 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-14 Tx date 2015-12-09 |
$ONC
Oncolytics Biotech Inc. |
SCHULTZ, ROBERT
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$20,000
+50,000 vol $0.40 each |
50,000 | |
| Filed 2015-12-14 Tx date 2002-12-18 |
$ONC
Oncolytics Biotech Inc. |
SCHULTZ, ROBERT
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-14 Tx date 2015-12-09 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$20,000
+50,000 vol $0.40 each |
50,000 | |
| Filed 2015-12-14 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-14 Tx date 2015-12-09 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$20,000
+50,000 vol $0.40 each |
50,000 | |
| Filed 2015-12-14 Tx date 2013-05-09 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-14 Tx date 2015-12-09 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$20,000
+50,000 vol $0.40 each |
50,000 | |
| Filed 2015-12-14 Tx date 2004-04-05 |
$ONC
Oncolytics Biotech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-14 Tx date 2015-12-09 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$20,000
+50,000 vol $0.40 each |
50,000 | |
| Filed 2015-12-14 Tx date 2014-06-18 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-14 Tx date 2015-12-09 |
$ONC
Oncolytics Biotech Inc. |
Dinning, James Francis
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$20,000
+50,000 vol $0.40 each |
50,000 | |
| Filed 2015-12-11 Tx date 2004-03-29 |
$ONC
Oncolytics Biotech Inc. |
Dinning, James Francis
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Awards
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-02 Tx date 2015-12-01 |
$ONC
Oncolytics Biotech Inc. |
Tuchman, Alan J
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,720
+116,000 vol $0.42 each |
246,000 | |
| Filed 2015-12-02 Tx date 2015-12-01 |
$ONC
Oncolytics Biotech Inc. |
Thompson, Bradley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$510,720
+1,216,000 vol $0.42 each |
2,488,160 | |
| Filed 2015-12-02 Tx date 2015-12-01 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$194,880
+464,000 vol $0.42 each |
947,700 | |
| Filed 2015-12-02 Tx date 2015-12-01 |
$ONC
Oncolytics Biotech Inc. |
Gill, George McClung
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+250,000 vol $0.42 each |
461,667 | |
| Filed 2015-12-02 Tx date 2015-12-01 |
$ONC
Oncolytics Biotech Inc. |
Coffey, Matthew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$308,280
+734,000 vol $0.42 each |
1,420,333 | |
| Filed 2015-06-18 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+50,000 vol $0.80 each |
50,000 | |
| Filed 2015-06-18 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-18 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+50,000 vol $0.80 each |
50,000 | |
| Filed 2015-06-18 Tx date 2015-06-08 |
$ONC
Oncolytics Biotech Inc. |
Rice, William Glenn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-05-27 Tx date 2015-05-26 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,350
+15,000 vol $0.89 each |
30,000 | |
| Filed 2015-05-26 Tx date 2015-05-26 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,450
+5,000 vol $0.89 each |
15,000 | |
| Filed 2015-05-14 Tx date 2015-05-12 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,149
+20,000 vol $0.76 each |
20,000 | |
| Filed 2015-05-14 Tx date 2015-05-12 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,149
+20,000 vol $0.76 each |
||
| Filed 2015-05-12 Tx date 2015-05-12 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,149
+20,000 vol $0.76 each |
20,000 |